Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author León Caballero, Jordica
  • dc.contributor.author Pacchiarotti, Isabellaca
  • dc.contributor.author Murru, Andreaca
  • dc.contributor.author Valentí, M.ca
  • dc.contributor.author Colom, Francescca
  • dc.contributor.author Benach, B.ca
  • dc.contributor.author Pérez Solá, Victorca
  • dc.contributor.author Dalmau, Josepca
  • dc.contributor.author Vieta, Eduardca
  • dc.date.accessioned 2015-11-17T11:16:29Z
  • dc.date.issued 2015
  • dc.description.abstract The high prevalence of comorbidity between bipolar disorder (BD) and other medical conditions, including autoimmune diseases, supports the hypothesis of the nature of BD as a biological illness category. Hence, an immune dysregulation process may play an important role in the development of at least certain subtypes of BD. Increasing evidence also suggests that the N-methyl-d-aspartate receptor (NMDAR) may be relevant in the pathophysiology of BD. A possible key mechanism underlying the physiopathology of certain autoimmune diseases that may present with affective symptoms might be the production of anti-NMDAR auto-antibodies (auto-Abs). The best characterized autoimmune anti-NMDAR disease is the anti-NMDAR encephalitis. It has been found that 4% of these patients present isolated, mostly affective, psychiatric manifestations during their illness. An interesting suggestion emerged from this overview is that the same mechanisms that trigger affective symptoms in patients with increased anti-NMDAR auto-Abs levels could be involved in the physiopathology of at least a subgroup of BD. Future studies are needed to characterize the relationship between anti-NMDAR auto-Abs and BD.ca
  • dc.description.sponsorship The authors ofthis report wouldlike to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (CP08/00140 and PI 12/00910), CIBERSAM (Exp. CB07/ 09/0004), the Spanish Ministry of Education and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2014 SGR 398).
  • dc.format.mimetype application/pdfca
  • dc.identifier.citation León-Caballero J, Pacchiarotti I, Murru A, Valentí M, Colom F, Benach B. et al. Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness. Neurosci Biobehav Rev. 2015 Aug;55:403-12. doi: 10.1016/j.neubiorev.2015.05.012ca
  • dc.identifier.doi http://dx.doi.org/10.1016/j.neubiorev.2015.05.012
  • dc.identifier.issn 0149-7634
  • dc.identifier.uri http://hdl.handle.net/10230/25110
  • dc.language.iso engca
  • dc.publisher Elsevierca
  • dc.relation.ispartof Neuroscience & Biobehavioral Reviews. 2015 Aug;55:403-12
  • dc.rights Copyright © 2015 Elsevier Ltd. All rights reserved.ca
  • dc.rights.accessRights info:eu-repo/semantics/openAccessca
  • dc.subject.other Psicosi maniacodepressivaca
  • dc.subject.other Autoimmunitatca
  • dc.subject.other Depressió psíquicaca
  • dc.title Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.ca
  • dc.type info:eu-repo/semantics/articleca
  • dc.type.version info:eu-repo/semantics/acceptedVersionca